SF3B1 AND MDS-RS: THE BIOLOGICAL PERSPECTIVE

被引：0
|
作者：
Fontenay, M. [1 ,2 ]
机构：
[1] Univ Paris Cite, Inst Cochin, INSERM, Paris, France
[2] Hop Cochin, Assistance Publ Hop Paris, Hematol, Paris, France
来源：
LEUKEMIA RESEARCH | 2023年 / 128卷
关键词：
D O I：
10.1016/j.leukres.2023.107092
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
IS14
引用
收藏
页数：1
相关论文
共 50 条
  • [21] The biological function and clinical significance of SF3B1 mutations in cancer
    Zhixia Zhou
    Qi Gong
    Yin Wang
    Mengkun Li
    Lu Wang
    Hongfei Ding
    Peifeng Li
    Biomarker Research, 8
  • [22] Role Of Sf3b1 On Hematopoiesis
    Matsunawa, Manabu
    Yamamoto, Ryo
    Sanada, Masashi
    Sato, Aiko
    Shiozawa, Yusuke
    Yoshida, Kenichi
    Nagata, Yasunobu
    Kon, Ayana
    Yoshizato, Tetsuichi
    Otsu, Makoto
    Isono, Kyoichi
    Koseki, Haruhiko
    Nakauchi, Hiromitsu
    Ogawa, Seishi
    BLOOD, 2013, 122 (21)
  • [23] Influence of SF3B1 gene mutation is different from that of Sf3B1 inhibitor in colorectal cancer
    Yamano, Tomoki
    Kubo, Shuji
    Matsubara, Nagahide
    Yano, Aya
    Tomita, Naohiro
    CANCER RESEARCH, 2014, 74 (19)
  • [24] Patient-specific MDS-RS iPSCs define the mis-spliced transcript repertoire and chromatin landscape of SF3B1-mutant HSPCs
    Asimomitis, Georgios
    G. Deslaurnes, Andre
    Kotini, Andriana G.
    Bernard, Elsa
    Esposito, Davide
    Olszewska, Malgorzata
    Spyrou, Nikolaos
    Ossa, Juan Arango
    Mortera-Blanco, Teresa
    Koche, Richard
    Malcovati, Luca
    Ogawa, Seishi
    Cazzola, Mario
    Aaronson, Stuart A.
    Hellstro-Lindberg, Eva
    Papaemmanuil, Elli
    Nannya, Yasuhito
    Papapetrou, Eirini P.
    BLOOD ADVANCES, 2022, 6 (10) : 2992 - 3005
  • [25] Isolated thrombocytosis in an elderly female: A very rare case of MDS/MPN-RS-T with SF3B1 and CALR type 1 mutation
    Wegener, N.
    Bankova, A.
    Mueller, J.
    Haralambieva, E.
    Bachli, E. B.
    Widmer, C. C.
    SWISS MEDICAL WEEKLY, 2018, 148 : 11S - 11S
  • [26] AUTOPHAGY STIMULATION IMPROVES ERYTHROID PROLIFERATIVE CAPACITY IN MODELS OF SF3B1 MUTANT MDS
    Visconte, V.
    Adema, V.
    Hirbawi, Y.
    Przychodzen, B.
    Kelly, K.
    Hirsch, C.
    Clemente, M.
    Balasubramanian, S.
    Carraway, H.
    Lindner, D.
    Sekeres, M.
    Rogers, H.
    Phillips, J.
    Radivoyevitch, T.
    Nawrocki, S.
    Carew, J.
    Maciejewski, J.
    LEUKEMIA RESEARCH, 2017, 55 : S36 - S36
  • [27] Isolated thrombocytosis in an elderly female: A very rare case of MDS/MPN-RS-T with SF3B1 and CALR type 1 mutation
    Wegener, N.
    Bankova, A.
    Mueller, J.
    Haralambieva, E.
    Bachli, E.
    Widmer, C.
    ONCOLOGY RESEARCH AND TREATMENT, 2018, 41 : 96 - 97
  • [28] SF3B1 and SF3B3 Expression in Tamoxifen Resistance
    Gokmen-Polar, Y.
    Nellamraju, Y.
    Goswami, C. P.
    Gu, X.
    Janga, S. C.
    Badve, S.
    LABORATORY INVESTIGATION, 2014, 94 : 50A - 50A
  • [29] SF3B1 and SF3B3 Expression in Tamoxifen Resistance
    Gokmen-Polar, Y.
    Nellamraju, Y.
    Goswami, C. P.
    Gu, X.
    Janga, S. C.
    Badve, S.
    MODERN PATHOLOGY, 2014, 27 : 50A - 50A
  • [30] Impact of SF3B1 mutation in myelofibrosis
    Senapati, Jayastu
    Verstovsek, Srdan
    Masarova, Lucia
    Pemmaraju, Naveen
    Patel, Keyur P.
    Montalban-Bravo, Guillermo
    Pierce, Sherry A.
    Zhou, Lingsha
    Garcia-Manero, Guillermo
    Kantarjian, Hagop M.
    Bose, Prithviraj
    LEUKEMIA & LYMPHOMA, 2022, 63 (11) : 2701 - 2705
12345